AA
EPRS

Apriem Advisors’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Apriem Advisors’s Portfolio EPRS Stock Details EPRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-500
Closed – – 685
2017
Q1 		$0 Hold
500
– – ﹤0.01% 788
2016
Q4 		$0 Hold
500
– – ﹤0.01% 792
2016
Q3 		$0 Hold
500
– – ﹤0.01% 706
2016
Q2 		$0 Hold
500
– – ﹤0.01% 694
2016
Q1 		$1K Buy
+500
New +$1.4K ﹤0.01% 571

Apriem Advisors's EPRS Position: Q2 2017 in Review

Apriem Advisors sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q2 2017, closing a stake of 500 shares.

Apriem Advisors first reported a position in EPRS in Q1 2016 and held it in 5 quarters. The position peaked at $1K in Q1 2016. 1 fund tracked by Wall St. Rank holds EPRS as of Q2 2017.

  • Apriem Advisors reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q2 2017 after selling out during the quarter.
  • Apriem Advisors sold 500 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q2 2017.
  • Apriem Advisors first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q1 2016 and held it in 5 quarters.
  • Apriem Advisors's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $1K in Q1 2016.
  • 1 fund tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q2 2017.

Based on Apriem Advisors's 13F filing for Q2 2017, filed 4 Aug 2017.